title: Expression of Na-K-Cl cotransporter and edema formation are age dependent after ischemic stroke.
abstract: Age is the most important independent risk factor for stroke; however aging animals are rarely used in stroke studies. Previous work demonstrated that young male mice had more edema formation after an induced stroke than aging animals. An important contributor to cerebral edema formation is the Na-K-Cl cotransporter (NKCC). We examined the expression of NKCC in young (10-12 weeks) and aging (15-16 months) C57BL6 male mice after middle cerebral artery occlusion (MCAO) and investigated the effect of pharmacological inhibition of NKCC with Bumetanide on cerebral edema formation. Both immunofluorescent staining and Western blotting analysis showed that NKCC expression was significantly higher in the ischemic penumbra of young compared to aging mice after stroke. Edema formation was significantly more robust in young mice and was reduced with Bumetanide. Bumetanide had no effect on cerebral edema in aging mice after MCAO. This suggests that NKCC expression and edema formation are age dependent after ischemic stroke.
authors.affiliation: Department of Neuroscience, University of Connecticut Health Center, Farmington, Connecticut, USA.
authors.forename: Fudong
authors.initials: F
authors.lastname: Liu
authors.forename: Padmastuti
authors.initials: P
authors.lastname: Akella
authors.forename: Sharon E
authors.initials: SE
authors.lastname: Benashski
authors.forename: Yan
authors.initials: Y
authors.lastname: Xu
authors.forename: Louise D
authors.initials: LD
authors.lastname: McCullough
mesh_terms: D000375:Aging / Q000502:physiology*; D000818:Animals; D001921:Brain / Q000378:metabolism; D001929:Brain Edema / Q000209:etiology / Q000378:metabolism* / Q000517:prevention & control; D002034:Bumetanide / Q000627:therapeutic use; D020244:Infarction, Middle Cerebral Artery / Q000150:complications; D002546:Ischemic Attack, Transient / Q000150:complications / Q000378:metabolism* / Q000517:prevention & control; D008297:Male; D051379:Mice; D008810:Mice, Inbred C57BL; D049994:Sodium Potassium Chloride Symporter Inhibitors / Q000627:therapeutic use; D028021:Sodium-Potassium-Chloride Symporters / Q000096:biosynthesis*
chemical_list: D049994:Sodium Potassium Chloride Symporter Inhibitors; D028021:Sodium-Potassium-Chloride Symporters; D002034:Bumetanide
references.citation: ScientificWorldJournal. 2007 Sep 28;7:1603-10
references.pmid: 17906823
references.citation: Lab Anim. 2006 Jan;40(1):1-8
references.pmid: 16460584
references.citation: J Exp Zool A Comp Exp Biol. 2003 Nov 1;300(1):63-8
references.pmid: 14598387
references.citation: Adv Neurol. 1996;71:301-11; discussion 311-3
references.pmid: 8790807
references.citation: J Biol Chem. 2005 May 27;280(21):20493-502
references.pmid: 15772080
references.citation: J Cereb Blood Flow Metab. 2005 Jan;25(1):54-66
references.pmid: 15678112
references.citation: Cerebrovasc Dis. 2008;25(1-2):176-84
references.pmid: 18212524
references.citation: J Neurochem. 2000 Jul;75(1):125-32
references.pmid: 10854255
references.citation: J Nippon Med Sch. 2007 Oct;74(5):332-7
references.pmid: 17965526
references.citation: J Neurochem. 1998 Jul;71(1):95-105
references.pmid: 9648855
references.citation: Brain Res. 2002 Jan 25;925(2):148-58
references.pmid: 11792363
references.citation: J Bioenerg Biomembr. 1998 Apr;30(2):161-72
references.pmid: 9672238
references.citation: Am J Physiol Cell Physiol. 2008 Jan;294(1):C88-96
references.pmid: 17942640
references.citation: J Biol Chem. 1992 Dec 15;267(35):25438-43
references.pmid: 1334094
references.citation: Am J Physiol. 1997 Jul;273(1 Pt 1):C188-97
references.pmid: 9252456
references.citation: Exp Gerontol. 1997 Jul-Oct;32(4-5):501-19
references.pmid: 9315452
references.citation: Brain Res. 2006 Nov 29;1122(1):222-9
references.pmid: 17014830
references.citation: Stroke. 1998 Feb;29(2):447-53
references.pmid: 9472888
references.citation: J Cereb Blood Flow Metab. 2004 Sep;24(9):1046-56
references.pmid: 15356425
references.citation: Eur J Neurol. 2007 Aug;14(8):895-9
references.pmid: 17662011
references.citation: J Cereb Blood Flow Metab. 2009 Apr;29(4):792-802
references.pmid: 19223913
references.citation: Biogerontology. 2009 Aug;10(4):377-413
references.pmid: 19381858
references.citation: Brain Res. 2001 Aug 17;911(1):43-55
references.pmid: 11489443
references.citation: J Biol Chem. 2008 Dec 5;283(49):33874-82
references.pmid: 18849345
references.citation: Neurol Res. 2005 Apr;27(3):280-6
references.pmid: 15845211
references.citation: Neurology. 2006 Mar 28;66(6):815-20
references.pmid: 16567697
references.citation: Brain Res. 2003 Jan 24;961(1):22-31
references.pmid: 12535773
references.citation: J Cereb Blood Flow Metab. 2005 Apr;25(4):502-12
references.pmid: 15689952
references.citation: J Cereb Blood Flow Metab. 2001 Jun;21(6):711-21
references.pmid: 11488540
references.citation: J Cereb Blood Flow Metab. 2008 Dec;28(12):1898-906
references.pmid: 18648381